# Neurocrine Biosciences Inc: Form 8-K, filed May 28, 2026

- Company: [Neurocrine Biosciences Inc](/companies/nbix.md) (CIK 914475)
- Form: 8-K
- Filed: 2026-05-28
- Accepted by EDGAR: May 28, 2026, 16:01 ET
- Period: 2026-05-27
- Accession: 0000914475-26-000029
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/914475/000091447526000029/nbix-20260527.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/914475/000091447526000029/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/914475/000091447526000029/nbix-20260527.htm

Filed May 28, 2026.
Source: SEC EDGAR, the filing index for accession 0000914475-26-000029. Last ingested by Listed: Nov 5, 2026, 17:26 ET. No prices; not investment advice.